Marketstrat Pulse Insights

The Operating Denominator: Radiology Partners’ Everlight Acquisition, 4DMedical & Actinium-225 Supply

Episode Description / Show Notes: 🎙️ Hosted by Zara, Marketstrat's automated AI voice. The medical imaging market is moving from permission-led commercialization toward

Operating Proof Over Permission: Pro Medicus’ AUD 261M Scale, Vitestro Robotics & FDA GenAI Guidance

🎙️ Hosted by Zara, Marketstrat's automated AI voice. The healthcare technology market is officially exiting the era of one-time regulatory permissions. Competitive advan

Monetization Control: Teledyne’s $1.1B Acquisition, RadNet’s $105M ARR & Case-Volume Economics

The medical imaging industry's center of gravity is shifting beyond simple regulatory authorizations and pilot agreements. Durable commercial value now concentrates with

The Capacity Control Stack: GE’s $500M Care Alliance, Automation Bias & Theranostic Supply

Healthcare operators and investors are witnessing a decisive structural shift: imaging value is aggressively moving away from standalone asset ownership and toward the ca

The 2027 OPPS Reset: SaMS Payments, Cardiac Staging & Ultrasound Capacity

Episode Description / Show Notes:The medical imaging AI market is facing a profound structural divergence between reimbursable clinical services and provider-funded produ

Beyond Clearance Counts: Supervised Report Drafting, Breast-AI Layering & Kaiser’s Capacity Proof

The medical imaging market has officially moved past algorithm clearance counts as the primary measure of commercial success. Capital and strategic advantage are now flow

Pulse Insights: Imaging AI’s Edge Shifts from Clearance to Fleet Capacity (June 19, 2026)

Welcome to the Marketstrat Pulse Insights audio briefing for the week ending June 19, 2026. In this edition, automated host Zara breaks down the fundamental structural sh

The Reporting Control Plane: RadNet's $250M Move, SIIM 2026 & The WISeR AI Backlash

The commercial center of gravity in medical imaging AI has broken away from standalone detection models. The new high-stakes competitive battleground is reporting-layer c

Platform Control over Point Solutions: Philips’ WellSpan Alliance, ProtégéAI+ 2.0 & Aetna's 15% Margin Cut

Episode Description / Show Notes:The medical imaging infrastructure market is undergoing a massive structural shift: platform control is entirely replacing point solution

Platform Control & Synthetic Capacity: The AUD 3.4B I-MED Deal, SubtleHD & Modality Repricing

The medical imaging infrastructure market is undergoing an aggressive repricing. The commercial center of gravity has definitively shifted from standalone AI detection mo

Infrastructure & Capacity Control: 1-Hour Bedside MRI, X-Ray AI Expansion & Supply Chain Realities

The medical imaging AI market has crossed a massive structural threshold. Value is moving definitively away from standalone detection models toward infrastructure that di

From Model Proof to Capacity Control: RadNet's AI Leverage, GE's Freelium & Siemens Optiq

The medical imaging AI market has crossed a massive threshold. The industry's focus has officially shifted from simply proving standalone models work to controlling the w

The Operating Era: Roche’s $1.05B PathAI Deal, AI Governance & OEM Margin Stress

We have officially entered the "Operating Era" of medical imaging AI. The market has shifted from simply proving algorithms work to deciding who controls the workflow and

The 2026 AI Playbook: Workflow Control, Aidoc's $150M Raise & GE's Margin Reset

The moat for imaging AI has officially shifted from isolated model performance to capitalized platform scale, workflow ownership, and operating leverage. This week on Mar

Coverage Speed is the New Moat: RAPID, Covera/Medmo & MRI Throughput

The market's center of gravity is moving from basic algorithm adoption to reimbursable, evidence-governed workflow infrastructure. This week on Marketstrat Pulse Insights

Owned Workflow Gets Paid: Reimbursable AI, Sectra M&A & ARRS Reality Checks

The era of the standalone AI algorithm is giving way to a new commercial reality: owned workflow surfaces are starting to get paid. This week on Marketstrat Pulse Insight

Platform Control, Breast AI Labor Proof & Cyber Reality Checks

Episode Description / Show Notes:The era of standalone medical AI is fading as tech giants move to own the digital infrastructure. This week on Marketstrat Pulse Insights

HIMSS26 & The AI Control Surface: Workflow, Helium Risk, and MIS Automation

Episode Description / Show Notes: The era of the standalone AI algorithm is officially over. This week on Marketstrat Pulse Insights for March 13, 2026, we break down the

Medical Imaging AI Grows Up: Consolidation, ECR 2026 & Reimbursement Reality Checks

Episode Summary:The era of the standalone medical AI algorithm is officially over. This week on Marketstrat Pulse Insights, AI host Marcus breaks down the rapid shift tow

RadNet’s $250M Gleamer Deal, GE’s "Virtual Capacity" & AI as Infrastructure

In this week’s Markintel Pulse (Week of Feb 27, 2026), we explore a massive shift in healthcare technology: AI is officially moving from a "shiny point-solution" to funda